Skip to main content
Ironclad logo

Ironclad

Security and trust center evidence

AI-powered contract management

ironcladapp.comLegal techLast verified 17 Sep 2026

Summary

Ironclad has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Ready. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 2026-09-17, Ironclad is listed in the FedRAMP registry with a status of 'FedRAMP Ready', with Tevora Business Solutions, Inc. named as auditor. As of 2026-09-17, Ironclad is listed in the CSA STAR registry with a STAR Level 1 self-assessment (CAIQ) and Trusted Cloud Provider status, originally issued 2021-09-10. As of 2026-09-17, Ironclad is listed in the EU-US Data Privacy Framework registry as Active across EU-US, Swiss-US, and UK Extension Certifications, issued 2024-10-25 and expiring 2026-10-01. No public evidence found for SOC 2 as of 2026-09-17. No public evidence found for HIPAA or a BAA offering as of 2026-09-17.

  • FedRAMP: listed in fedramp registry as 'FedRAMP Ready' (auditor: Tevora Business Solutions, Inc.), as of 2026-09-17.
  • CSA STAR: listed in csa_star registry as STAR Level 1 self-assessment (CAIQ), Trusted Cloud Provider, issued 2021-09-10, as of 2026-09-17.
  • EU-US Data Privacy Framework: listed in dpf registry as Active (EU-US, SW-US, UK Extension Certifications), issued 2024-10-25, expires 2026-10-01, as of 2026-09-17.

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among legal tech vendors

3verified rows

Category median 1, across 34 indexed legal tech vendors. Ironclad has more verified rows than 100 percent of them.

ai-poweredcollaborationcontract managementnegotiation

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Legal tech category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.